Heart Diseases : Health & Medical
Links between gut microbiota metabolism, TMAO formation, and cardiorenal pathophysiology are explored.
Digital blood pressure monitors are the latest in home health care systems. They have become a necessity to most people suffering from hypertension. To help the users choose the monitors based on their requirements, some of the top brands in pressure monitors are rated against the most popular and r
Will central BP management prove to be feasible -- in terms of patient outcomes?
In a study by the University of Texas and the Center for Adult Diseases in Japan, Coenzyme Q10, CoQ10 for short, was shown to lower high blood pressure without drugs or dietary changes. Promising research is being done to show efficacy in reducing mortality in experimental animals afflicted with tum
According to the Center for Disease Control and Prevention (CDC) in the United States, nearly 40 per cent of it's population is obese. The number of obese children have tripled over the last 2 decades. Despite the exhortations of different health experts to eat less and exercise more, millions
An international group of experts in epidemiology, clinical and basic science formed a consensus that an HDLc concentration of 1.0 mmol/L is a realistic clinical guideline for high risk patients.
Dr. Henry Black discusses the future of rimonabant and endocannabinoid inhibitors. Will their effectiveness in curbing weight in high-risk individuals compensate for the depression linked with usage?
Get the verdict from comparing 3 therapeutic strategies for stable multivessel CAD in a diabetic vs non-diabetic populations.
Do You Understand The Risks of Coronary Heart Disease?Unfortunately, in one third of all cases the first sign of coronary heart disease is sudden, unexpected death. The victims are completely unaware of the blockages in their coronary arteries until it is too late.In the rest of the cases, coronary
CitationsAwtry EH, Loscalzo J (2000). Aspirin. Circulation, 101(10): 1206–1218.Danchin N, et al. (2004). Acute myocardial infarction. Clinical Evidence (12): 20–50. Freestone B, et al. (2003). Stroke prevention. Clinical Evidence (11): 257–283.Kurth T, et al. (2003). Inhibition of clinical benefits
What factors influence the potential of CCTA to serve as an effective gatekeeper to invasive coronary angiography?
Thyroid problems from amiodarone are common, and can be difficult to diagnose and to treat.